°³¿ä
Ç÷·ùÃøÁ¤±â±â´Â ÀÎü ³» Ç÷·ù¿¡ Á¢±ÙÇϰí Á¤·®ÈÇϱâ À§ÇØ ¼³°èµÇ¾ú½À´Ï´Ù. ÀÌ Àåºñ´Â ½ÉÀåÇÐ, Ç÷°ü ¼ö¼ú, ½Å°æÇÐ µî ´Ù¾çÇÑ ÀÇ·á Àü¹® ºÐ¾ß¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.
Ç÷·ù°è´Â ´Ù¾çÇÑ Ç÷°üÀÇ Ç÷·ù¸¦ ¸ð´ÏÅ͸µÇÏ°í ½É¹ÚÃâ·®À» ÃøÁ¤ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÃÊÀ½ÆÄ µµÇ÷¯, Åë°ú½Ã°£ À¯·®°è, ÀüÀÚ±â½Ä Ç÷·ù°è, ÇÁ·¹Æ¼½º¸ð±×·¡ÇÇ Ã¨¹ö À¯·®°è µîÀÌ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â Ç÷·ù ÃøÁ¤ ÀåÄ¡ÀÔ´Ï´Ù.
½ÃÀå ¿ªÇÐ
Á¦Ç° Ãâ½Ã Áõ°¡
¹ß Ç÷·ù ÃøÁ¤ ÀåÄ¡ÀÇ Á¦Ç° Ãâ½Ã°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀÇ Áß¿äÇÑ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸¹Àº ÁÖ¿ä ±â¾÷µéÀÌ »õ·Î¿î Ç÷·ù ÃøÁ¤ ÀåÄ¡¸¦ Ãâ½ÃÇÏ¿© ½ÃÀå ¹ßÀü¿¡ Å« ¿ªÇÒÀ»Çϰí ÀÖ½À´Ï´Ù.
¿¹¸¦ µé¾î, 2023³â 6¿ù Stat Health´Â Ç÷·ù·®À» ÃøÁ¤ÇÏ´Â ±Í¿¡ Âø¿ëÇÏ´Â ¿þ¾î·¯ºíÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ¿þ¾î·¯ºíÀº ¾îÁö·³Áõ, ³ú ¾È°³, µÎÅë, ½Ç½Å, ÇÇ·Î µîÀÇ Áõ»óÀ» ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ 2021³â 4¿ù, NovaSignal Corp.´Â ÀÚÀ²ÀûÀ¸·Î Ç÷·ù¸¦ ÃøÁ¤ÇÏ¿© ³úÀÇ Áúº´°ú ÁúȯÀ» ½Äº°ÇÏ´Â NovaGuide 2 Intelligent Ultrasound¸¦ Ãâ½ÃÇÏ¿´½À´Ï´Ù.
¶ÇÇÑ, ¼¼°è Ç÷·ù ÃøÁ¤ ½ÃÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, ±â¼ú ¹ßÀü, Ç÷·ùÃøÁ¤±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¾ö°ÝÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ
Ç÷·ùÃøÁ¤±â±â¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ¾ö°ÝÇÑ ½ÂÀÎÀº Á¤È®¼º, ½Å·Ú¼º ¹× ¾ÈÀü¼º¿¡ ´ëÇÑ Æ¯Á¤ ±âÁØÀ» º¸ÀåÇϱâ À§ÇØ Àåºñ¿¡ ´ëÇÑ ¾ö°ÝÇÑ Å×½ºÆ® ¹× Æò°¡¸¦ ¼ö¹ÝÇϱ⠶§¹®¿¡ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§
Á¦2Àå Á¤ÀÇ¿Í °³¿ä
Á¦3Àå ÁÖ¿ä ¿ä¾à
Á¦4Àå ½ÃÀå ¿ªÇÐ
- ¿µÇâ¿äÀÎ
- ¼ºÀå ÃËÁø¿äÀÎ
- ¼ºÀå ¾ïÁ¦¿äÀÎ
- ±âȸ
- ¿µÇ⠺м®
Á¦5Àå »ê¾÷ ºÐ¼®
- PorterÀÇ Five Forces ºÐ¼®
- °ø±Þ¸Á ºÐ¼®
- °¡°Ý ºÐ¼®
- ±ÔÁ¦ ºÐ¼®
- DMIÀÇ °ßÇØ
Á¦6Àå COVID-19 ºÐ¼®
Á¦7Àå ±â±â À¯Çüº°
- ÃÊÀ½ÆÄ ±â±â
- ÃÊÀ½ÆÄ µµÇ÷¯
- Transit-Time Flow Meters
- ·¹ÀÌÀú µµÇ÷¯
- ÀüÀÚ½Ä Ç÷·ù°è
- Plethysmography Chamber Flow meter
Á¦8Àå ¿ëµµº°
- ħ½ÀÀû
- ºñħ½ÀÀû
- ´ç´¢º´
- ½ÉÇ÷°üÁúȯ
- Á¾¾ç ¸ð´ÏÅ͸µ
- ¼Òȱ⺴ÇÐ
- ±âŸ
Á¦9Àå ÃÖÁ¾»ç¿ëÀÚº°
- º´¿ø
- Ŭ¸®´Ð
- ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
- ±âŸ
Á¦10Àå Áö¿ªº°
- ºÏ¹Ì
- À¯·´
- µ¶ÀÏ
- ¿µ±¹
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ±âŸ À¯·´
- ³²¹Ì
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- ±âŸ ³²¹Ì
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- Àεµ
- ÀϺ»
- È£ÁÖ
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦11Àå °æÀï ±¸µµ
- °æÀï ½Ã³ª¸®¿À
- ½ÃÀå ÇöȲ/Á¡À¯À² ºÐ¼®
- M&AºÐ¼®
Á¦12Àå ±â¾÷ °³¿ä
- Cook Medical Inc.
- ±â¾÷ °³¿ä
- Á¦Ç° Æ÷Æ®Æú¸®¿À¿Í ¼³¸í
- À繫 °³¿ä
- ÁÖ¿ä ¹ßÀü
- Medistim ASA
- Transonic Systems, Inc.
- Deltex Medical Group PLC
- Biopac Systems Inc.
- ATYS Medical
- Perimed AB
- ADInstruments
- Getinge AB
- Compumedics Limited
Á¦13Àå ºÎ·Ï
LSH
Overview
Blood flow measurement devices are designed to access and quantify blood flow within the human body. These devices play a crucial role in various medical specialties including cardiology, vascular surgery, and neurology.
Blood flow meters are used to monitor the blood flow in various blood vessels and to measure cardiac output. Ultrasound doppler, transit-time flow meters, electromagnetic blood flowmeters, and plethysmography chamber flow meters are the commonly used blood flow measurement devices.
Market Dynamics
Increasing product launches
The increasing number of product launches for foot blood flow measurement devices acts as a significant driver for market growth. Also, many significant companies play a major role in the advancements of the market by launching new blood flow measurement devices.
For instance, in June 2023, Stat Health launched an in-ear wearable that measures blood flow. It is designed wearable to help understand symptoms like dizziness, brain fog, headaches, fainting, and fatigue.
Additionally, in April 2021, NovaSignal Corp. launched the NovaGuide 2 Intelligent Ultrasound which autonomously measures the blood flow to identify brain illnesses and diseases.
Furthermore, the global blood flow measurement market is driven by various factors like the rising prevalence of cardiovascular diseases, technological advancements, and a rise in demand for blood flow measurement devices are expected to drive the market in the forecast period.
Stringent regulatory approvals
Stringent regulatory approvals for blood flow measurement devices can hamper the market growth as they involve rigorous testing and evaluation of the device to ensure specific standards for accuracy, reliability, and safety.
Segment Analysis
The global blood flow measurement market is segmented based on device type, application, end users and region.
Ultrasound devices accounted for approximately 38.9% of the market share
Doppler ultrasound is a noninvasive test that can be used to estimate the blood flow through the blood vessels by bouncing high-frequency sound waves. Ultrasound devices are expected to hold the largest market share over the period forecast owing to increasing new standard device launches and technological advancements.
For instance, in February 2022, Philips expanded its ultrasound portfolio with advanced hemodynamic assessment and measurement capabilities for real-time blood flow on its handheld point-of-care ultrasound called Lumify.
Additionally, in August 2021, Trivitron launched SonoRad V60 Ultrasound. The device is equipped with innovative color flow technology that improves blood flow measurement and visualization and offers a 3D-like flow impression.
Geographical Analysis
North America is expected to hold a significant position in the global blood flow measurement devices market share
The global blood flow measurement devices market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.
North America has maintained a significant market proportion due to factors such as the rising prevalence of cardiovascular disorders, and product launches, this trend is anticipated to continue throughout the forecast period.
For instance, according to the Centers for Disease Control and Prevention 2023 report, in the United States, heart disease is the top cause of death for both men and women. In the US, an estimated 805,000 people suffer a heart attack annually. Hence, the requirement for blood flow measurement devices increases due to the rising prevalence of cardiovascular diseases.
Additionally, in April 2023, GE HealthCare launched its next-generation intraoperative ultrasound called bkActiv system. It features a sensitive color Doppler to visualize and measure the speed and direction of blood flow during complex surgical procedures.
COVID-19 Impact Analysis:
The COVID-19 pandemic has had a significant impact on the global blood flow measurement devices market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatments, device launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the blood flow measurement devices market is expected to be moderately affected over the forecast period.
Competitive Landscape
The major global players in the market include: Cook Medical Inc., Medistim ASA, Transonic Systems, Inc., Deltex Medical Group PLC, Biopac Systems Inc., ATYS Medical, Perimed AB, ADInstruments, Getinge AB, Compumedics Limited among others.
Key Developments
- In September 2023, Us2.ai partnered with Academic Medical Center to collaborate on AI-enabled echocardiography software. Us2.ai software automated measurements include 2-dimensional spectral Doppler and tissue Doppler.
Why Purchase the Report?
- To visualize the global blood flow measurement devices market segmentation based on device type, application, end users and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of blood flow measurement devices market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global blood flow measurement devices market report would provide approximately 61 tables, 58 figures, and 185 Pages.
Target Audience 2023
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
Table of Contents
1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
- 3.1. Snippet by Device Type
- 3.2. Snippet by Application
- 3.3. Snippet by End User
- 3.4. Snippet by Region
4. Market Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Increasing product launches
- 4.1.1.2.
- 4.1.2. Restraints
- 4.1.2.1. Stringent regulatory approvals
- 4.1.2.2.
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
5. Industry Analysis
- 5.1. Porter's Five Force Analysis
- 5.2. Supply Chain Analysis
- 5.3. Pricing Analysis
- 5.4. Regulatory Analysis
- 5.5. DMI Opinion
6. COVID-19 Analysis
- 6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
- 6.2. Pricing Dynamics Amid COVID-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During Pandemic
- 6.5. Manufacturers Strategic Initiatives
- 6.6. Conclusion
7. By Device Type
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 7.1.2. Market Attractiveness Index, By Device Type
- 7.2. Ultrasound Devices *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.2.3. Ultrasound Doppler
- 7.2.4. Transit-Time Flow Meters
- 7.3. Laser Doppler
- 7.4. Electromagnetic Blood Flowmeters
- 7.5. Plethysmography Chamber Flow meter
8. By Application
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
- 8.2. Invasive *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.2.3. CABG
- 8.2.4. Microvascular Surgery
- 8.3. Non-Invasive
- 8.3.1. Diabetes
- 8.3.2. Cardiovascular Disease
- 8.3.3. Tumor Monitoring
- 8.3.4. Gastroenterology
- 8.3.5. Others
9. By End Users
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
- 9.1.2. Market Attractiveness Index, By End Users
- 9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.3. Clinics
- 9.4. Ambulatory Surgical Centers
- 9.5. Others
10. By Region
- 10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
- 10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.2.6.1. U.S.
- 10.2.6.2. Canada
- 10.2.6.3. Mexico
- 10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.3.6.1. Germany
- 10.3.6.2. UK
- 10.3.6.3. France
- 10.3.6.4. Italy
- 10.3.6.5. Spain
- 10.3.6.6. Rest of Europe
- 10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.4.6.1. Brazil
- 10.4.6.2. Argentina
- 10.4.6.3. Rest of South America
- 10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.5.7.1. China
- 10.5.7.2. India
- 10.5.7.3. Japan
- 10.5.7.4. Australia
- 10.5.7.5. Rest of Asia-Pacific
- 10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
11. Competitive Landscape
- 11.1. Competitive Scenario
- 11.2. Market Positioning/Share Analysis
- 11.3. Mergers and Acquisitions Analysis
12. Company Profiles
- 12.1. Cook Medical Inc.
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
- 12.2. Medistim ASA
- 12.3. Transonic Systems, Inc.
- 12.4. Deltex Medical Group PLC
- 12.5. Biopac Systems Inc.
- 12.6. ATYS Medical
- 12.7. Perimed AB
- 12.8. ADInstruments
- 12.9. Getinge AB
- 12.10. Compumedics Limited
LIST NOT EXHAUSTIVE.
13. Appendix
- 13.1. About Us and Services
- 13.2. Contact Us